Vol. 74, Issue 6, 2013November 01, 2013 EDT
Direct-to-Consumer Genomic Testing Offers Little Clinical Utility but Appears to Cause Minimal Harm
Direct-to-Consumer Genomic Testing Offers Little Clinical Utility but Appears to Cause Minimal Harm
Adams, Stacie D., James P. Evans, and Arthur S. Aylsworth. 2013. “Direct-to-Consumer Genomic Testing Offers Little Clinical Utility but Appears to Cause Minimal Harm.” North Carolina Medical Journal 74 (6): 494–99. https://doi.org/10.18043/ncm.74.6.494.
Powered by Scholastica, the modern academic journal management system